|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/20 | (2006.01) |
| A61K 38/26 | (2006.01) | ||
| A61P 3/04 | (2006.01) | ||
| A61P 3/10 | (2006.01) |
| (11) | Number of the document | 2651398 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11805824.7 |
| Date of filing the European patent application | 2011-12-16 | |
| (97) | Date of publication of the European application | 2013-10-23 |
| (45) | Date of publication and mention of the grant of the patent | 2017-12-13 |
| (46) | Date of publication of the claims translation | 2018-03-26 |
| (86) | Number | PCT/EP2011/073060 |
| Date | 2011-12-16 |
| (87) | Number | WO 2012/080471 |
| Date | 2012-06-21 |
| (30) | Number | Date | Country code |
| 10195285 | 2010-12-16 | EP | |
| 201061425087 P | 2010-12-20 | US |
| (72) |
SAUERBERG, Per, DK
BJERREGAARD, Simon, DK
NIELSEN, Flemming Seier, DK
|
| (73) |
Novo Nordisk A/S,
Novo Allé, 2880 Bagsvęrd,
DK
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Kietos kompozicijos, apimančios GLP-1 agonistą ir N-(8-(2-hidroksibenzoil)amino)oktano rūgšties druską |
| SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID |
| Payment date | Validity (years) | Amount | |
| 2024-11-21 | 14 | 289.00 EUR |
| 2025-12-16 |